2011Journal of Rheumatic DiseasesOpen access

The Effect of Hypouricemic Treatment on the Renal Function in Patients with Gout

So Young Jo, Yong‐Beom Park, Chan Hee Lee

Open full text 2 citations

Abstract

Objective.Hyperuricemia is known as a risk factor that causes and worsens kidney diseases through a variety of mechanisms.Recent animal studies reported that the correction of hyperuricemia improved the renal function, but there have been few human studies.This study examined whether a hypouricemic treatment affects the renal function in Korean patients with gout.Methods.Two hundred sixty-seven gout patients who were prescribed uric acid lowering agents for more than 1 year were enrolled at the Division of Rheumatology in the National Health Insurance Corporation Ilsan Hospital and Yonsei University Severance Hospital from January 2005 to January 2010.The following were examined: the levels of serum uric acid and serum creatinine, the amount of 24-hour urine uric acid, glomerular filtration rate (GFR), and abdominal ultrasound findings at baseline and follow-up.Results.Mean age of the study subjects was 54.4±13.9years.Two hundred forty-seven patients were male and 20 patients were female.The mean treatment duration was 35.0±19.5 months.Among the 267 patients, 219 and 19 patients received monotherapy with allopurinol and benzbromarone respectively, and 29 patients received combination therapy with allopurinol and benzbromarone.After the treatment with uric acid lowering agents, the serum uric acid and creatinine levels decreased significantly (8.05±1.96mg/dL vs 6.16±1.46mg/dL, p<0.001, 1.25±0.46mg/dL vs 1.18±0.42mg/dL, p=0.001, respectively) and the GFR increased significantly (74.4±27.0mL/min/1.73m 3 vs 80.2±31.6 mL/min/1.73m 3 , p<0.001).Conclusion.Treatment with hypouricemic agents reduced the levels of serum uric acid and improved the renal function.These results suggest that a hypouricemic treatment might improve the kidney function in gout patients.Key Words.Gout, Renal function, Hypouricemic treatment 서 론 통풍은 요산의 체내 과잉 합성이나 배설 장애로 인하여 고요산혈증이 발생되고 요산 일 나트륨 결정(monosodium urate crystal)이 조직에 침착 되어 염증과 통증을 일으키는 질환으로 급성 통풍성 관절염, 만성 통풍 결절성 관절염, 요로계의 요석, 통풍성 신병증 등의 다양한 임상 양상을 보인다 (1).

Open-access reader

About this research paper

What this paper is about

Objective.Hyperuricemia is known as a risk factor that causes and worsens kidney diseases through a variety of mechanisms.Recent animal studies reported that the correction of hyperuricemia improved the renal function, but there have been few human studies.This study examined whether a hypouricemic treatment affects the renal function in Korean patients with gout.Methods.Two hundred sixty-seven gout patients who were prescribed uric acid lowering agents for more than 1 year were enrolled at the Division of Rheumatology in the National Health Insurance Corporation Ilsan Hospital and Yonsei University Severance Hospital from January 2005 to January 2010.The following were examined: the levels of serum uric acid and serum creatinine, the amount of 24-hour urine uric acid, glomerular filtration rate (GFR), and abdominal ultrasound findings at baseline and follow-up.Results.Mean age of the study subjects was 54.4±13.9years.Two hundred forty-seven patients were male and 20 patients were female.The mean treatment duration was 35.0±19.5 months.Among the 267 patients, 219 and 19 patients received monotherapy with allopurinol and benzbromarone respectively, and 29 patients received combination therapy with allopurinol and benzbromarone.After the treatment with uric acid lowering agents, the serum uric acid and creatinine levels decreased significantly (8.05±1.96mg/dL vs 6.16±1.46mg/dL, p<0.001, 1.25±0.46mg/dL vs 1.18±0.42mg/dL, p=0.001, respectively) and the GFR increased significantly (74.4±27.0mL/min/1.73m 3 vs 80.2±31.6 mL/min/1.73m 3 , p<0.001).Conclusion.Treatment with hypouricemic agents reduced the levels of serum uric acid and improved the renal function.These results suggest that a hypouricemic treatment might improve the kidney function in gout patients.Key Words.Gout, Renal function, Hypouricemic treatment 서 론 통풍은 요산의 체내 과잉 합성이나 배설 장애로 인하여 고요산혈증이 발생되고 요산 일 나트륨 결정(monosodium urate crystal)이 조직에 침착 되어 염증과 통증을 일으키는 질환으로 급성 통풍성 관절염, 만성 통풍 결절성 관절염, 요로계의 요석, 통풍성 신병증 등의 다양한 임상 양상을 보인다 (1).

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective.Hyperuricemia is known as a risk factor that causes and worsens kidney diseases through a variety of mechanisms.Recent animal studies reported that the correction of hyperuricemia improved the renal function, but there have been few human studies.This study examined whether a hypouricemic treatment affects the renal function in Korean patients with gout.Methods.Two hundred sixty-seven gout patients who were prescribed uric acid lowering agents for more than 1 year were enrolled at the Division of Rheumatology in the National Health Insurance Corporation Ilsan Hospital and Yonsei University Severance Hospital from January 2005 to January 2010.The following were examined: the levels of serum uric acid and serum creatinine, the amount of 24-hour urine uric acid, glomerular filtration rate (GFR), and abdominal ultrasound findings at baseline and follow-up.Results.Mean age of the study subjects was 54.4±13.9years.Two hundred forty-seven patients were male and 20 patients were female.The mean treatment duration was 35.0±19.5 months.Among the 267 patients, 219 and 19 patients received monotherapy with allopurinol and benzbromarone respectively, and 29 patients received combination therapy with allopurinol and benzbromarone.After the treatment with uric acid lowering agents, the serum uric acid and creatinine levels decreased significantly (8.05±1.96mg/dL vs 6.16±1.46mg/dL, p<0.001, 1.25±0.46mg/dL vs 1.18±0.42mg/dL, p=0.001, respectively) and the GFR increased significantly (74.4±27.0mL/min/1.73m 3 vs 80.2±31.6 mL/min/1.73m 3 , p<0.001).Conclusion.Treatment with hypouricemic agents reduced the levels of serum uric acid and improved the renal function.These results suggest that a hypouricemic treatment might improve the kidney function in gout patients.Key Words.Gout, Renal function, Hypouricemic treatment 서 론 통풍은 요산의 체내 과잉 합성이나 배설 장애로 인하여 고요산혈증이 발생되고 요산 일 나트륨 결정(monosodium urate crystal)이 조직에 침착 되어 염증과 통증을 일으키는 질환으로 급성 통풍성 관절염, 만성 통풍 결절성 관절염, 요로계의 요석, 통풍성 신병증 등의 다양한 임상 양상을 보인다 (1).

Key concepts: Benzbromarone, Medicine, Gout, Hyperuricemia, Renal function, Allopurinol, Uric acid, Creatinine

Related papers

Back to paper searchBrowse research topicsOriginal source
The Effect of Hypouricemic Treatment on the Renal Function in Patients with Gout — Research Paper | ScholarLens